BioCryst: The Stock Price Is At A Turning Point

Biocryst Pharmaceuticals’ (Nasdaq:BCRX) stock price has marked a fall in recent days to reach $1.38 as of Nov. 14, 2019). The cumulative reduction in recent sessions has been significant with a cumulative setback of 50% for a month and a half. On Nov. 12, 201…

Click here to view the original article.